Key Opioids Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The global opioids market is a complex landscape. The market is featuring a blend of major multinational pharmaceutical companies and up-and-coming generic manufacturers. Leading the charge are U.S.-based giants like Johnson & Johnson and Purdue Pharma. These companies stay ahead by innovating in abuse-deterrent formulations and maintaining extensive distribution networks. European and Israeli companies are making their mark by offering generics that appeal to cost-conscious consumers. Asian manufacturers are quickly broadening their reach by focusing on affordable generics and local production.
Here is a list of key players operating in the global opioids market:
|
Company Name |
Country |
Market Share (%) |
|
Johnson & Johnson |
USA |
12.1 |
|
Purdue Pharma |
USA |
9.4 |
|
Teva Pharmaceutical Industries |
Israel |
7.5 |
|
Mylan N.V. (now part of Viatris) |
USA |
6.6 |
|
Endo International |
USA |
5.4 |
|
Hikma Pharmaceuticals |
UK |
xx |
|
Mundipharma International |
UK |
xx |
|
Pfizer Inc. |
USA |
xx |
|
Sun Pharmaceutical Industries |
India |
xx |
|
Aurobindo Pharma |
India |
xx |
|
Daiichi Sankyo |
Japan |
xx |
|
Kyowa Kirin |
Japan |
xx |
|
Aspen Pharmacare |
South Africa |
xx |
|
Seqirus (part of CSL Limited) |
Australia |
xx |
|
GlaxoSmithKline |
UK |
xx |
|
Cipla Limited |
India |
xx |
|
Hanmi Pharmaceutical Co. |
South Korea |
xx |
|
Baxter International |
USA |
xx |
|
MundiPharma |
UK |
xx |
|
Malaysian Pharma Sdn Bhd |
Malaysia |
xx |
Below are the areas covered for each company in the opioids market: